logo

For the Inventor, By the Inventor

Matsudo, Japan

Teruomi Ito

This inventor holds 5 USPTO granted patents. Top assignee: Drug Delivery System Institute, Ltd.. Active years: 1995-1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Teruomi Ito. Retrieved from https://idiyas.com/inventor/teruomi-ito

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 5

% Patents Active = 100.0

Average Co-Inventor Count = 5.5

ph-index = 3

Forward Citations = 17(Granted Patents)


Company Filing History:

goldMedal5 out of 12 
 
Drug Delivery System Institute, Ltd.
 patents

Years Active: 1995-1999

Loading Chart...
5 patents (USPTO):Explore Patents
1. 5863908 - Carboxymethylmannoglucans and derivatives thereof (1999-01-26),
2. 5863907 - Carboxymethylmannoglucans and derivatives thereof (1999-01-26),
3. 5580904 - Formamido and carboxyamido compounds which can be retained in brain (1996-12-03),
4. 5567690 - Carboxymethylmannoglucans and derivatives thereof (1996-10-22),
5. 5463022 - N-acetylcarboxymethylchitosan derivatives and process for preparation (1995-10-31),

Title: Teruomi Ito: Innovator in Drug Delivery Systems

Introduction

Teruomi Ito is a prominent inventor based in Matsudo, Japan. He has made significant contributions to the field of drug delivery systems, holding a total of 5 patents. His work focuses on innovative compounds that enhance the effectiveness of drug therapies.

Latest Patents

One of Teruomi Ito's latest patents is related to carboxymethylmannoglucans and their derivatives. This invention describes a carboxymethylmannoglucan that comprises tetrasaccharide units represented by a specific general formula. The patent further discloses a derivative produced by modifying mannose and glucose components of the tetrasaccharide units. These compounds are particularly useful as carriers that delay the disappearance of drugs in the bloodstream and enhance their targeting to carcinoma tissues.

Career Highlights

Teruomi Ito is associated with the Drug Delivery System Institute, Ltd., where he continues to develop innovative solutions in drug delivery. His research has led to advancements that could significantly improve therapeutic outcomes for patients.

Collaborations

He has collaborated with notable colleagues such as Kazuhiro Inoue and Satoshi Okuno, contributing to the advancement of drug delivery technologies.

Conclusion

Teruomi Ito's work exemplifies the intersection of innovation and healthcare, showcasing how targeted drug delivery systems can transform treatment methodologies. His contributions are paving the way for more effective therapies in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…